Proteomics

Dataset Information

0

LC-MS/MS identification of Mycolactone protein targets


ABSTRACT: Mycolactone is a diffusible macrolide produced by the skin pathogen Mycobacterium ulcerans that suppresses the development of protective immunity against Buruli ulcer disease. In this proteomics study we aimed to identify proteins of which the expression levels changed upon mycolactone treatment. Jurkat T cells were labeled light or heavy by stable isotope labeling by amino acids in cell culture (SILAC), then treated with mycolactone (light) or vehicle (heavy) for 1h prior to activation with PMA/IO for 6h. After mixing light- and heavy-labeled cultures, cells were lysed and extracted proteins were digested with trypsin. The resulting peptide mixture was analyzed by LC-MS/MS and proteins were identified by the MaxQuant software and quantified based on the intensity of the light and heavy signals in the MS spectra of their peptides. The analysis was repeated with reversed labeling, leading to a total of 4,636 proteins that were quantified in both analyses. Interestingly, 52 proteins were down-regulated in mycolactone-treated cells (mycolactone/control ratio < 1.4), while only two proteins were up-regulated (mycolactone/control ratio > 1.4). Gene ontology analysis further revealed that the down-regulated proteins were significantly enriched in proteins located in the plasma membrane and endoplasmic reticulum and we could show that this enrichment was not due to a bias in protein extraction, since the distribution of all identified proteins across different subcellular compartments was similar to those of all human proteins. Analysis of SP-PIR Family-Domains keywords in the UniProt database confirmed this observation and showed an additional enrichment in glycoproteins, proteins with an immunoglobulin domain and proteins involved in immune responses. Furthermore, we observed that the down-regulated proteins were significantly enriched in single-pass type I/II membrane proteins. In contrast, the fraction of multi-pass membrane proteins was comparable among the down-regulated and all identified proteins, suggesting that multi-pass membrane proteins may at least partially resist mycolactone-mediated down-regulation.

INSTRUMENT(S): Q Exactive

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): T Cell, Cell Culture, T-lymphocyte Cell Line, Jurkat Cell

DISEASE(S): Buruli Ulcer Disease

SUBMITTER: Francis Impens  

LAB HEAD: Caroline Demangel

PROVIDER: PXD002971 | Pride | 2016-11-04

REPOSITORIES: Pride

altmetric image

Publications

Proteomics Reveals Scope of Mycolactone-mediated Sec61 Blockade and Distinctive Stress Signature.

Morel Jean-David JD   Paatero Anja O AO   Wei Jiajie J   Yewdell Jonathan W JW   Guenin-Macé Laure L   Van Haver Delphi D   Impens Francis F   Pietrosemoli Natalia N   Paavilainen Ville O VO   Demangel Caroline C  

Molecular & cellular proteomics : MCP 20180618 9


Mycolactone is a bacteria-derived macrolide that blocks the biogenesis of a large array of secretory and integral transmembrane proteins (TMP) through potent inhibition of the Sec61 translocon. Here, we used quantitative proteomics to delineate the direct and indirect effects of mycolactone-mediated Sec61 blockade in living cells. In T lymphocytes, dendritic cells and sensory neurons, Sec61 substrates downregulated by mycolactone were in order of incidence: secretory proteins (with a signal pept  ...[more]

Similar Datasets

2015-03-06 | E-GEOD-59792 | biostudies-arrayexpress
2019-04-03 | PXD011136 | Pride
2014-03-26 | E-GEOD-56186 | biostudies-arrayexpress
2022-02-17 | PXD025052 | Pride
2011-04-22 | E-GEOD-28813 | biostudies-arrayexpress
2015-01-06 | PXD001529 | Pride
2019-10-02 | PXD014533 | Pride
2020-03-31 | PXD016004 | Pride
2021-05-06 | PXD023703 | Pride
2019-07-11 | PXD012066 | Pride